TC
FATE icon

TFS Capital’s Fate Therapeutics FATE Stock Holding History

TFS Capital’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-34,107
Closed -$111K – 119
2017
Q2 		$111K Sell
34,107
-20,491
-38% -$78.5K 0.04% 536
2017
Q1 		$248K Buy
+54,598
New +$200K 0.08% 418
2016
Q3 		– Sell
-20,925
Closed -$36K – 817
2016
Q2 		$36K Buy
+20,925
New +$37.9K 0.01% 927
2016
Q1 		– Sell
-32,495
Closed -$110K – 1021
2015
Q4 		$110K Sell
32,495
-88,656
-73% -$373K 0.01% 648
2015
Q3 		$646K Buy
121,151
+39,354
+48% +$269K 0.06% 447
2015
Q2 		$529K Buy
+81,797
New +$489K 0.05% 507

Other funds holding FATE

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return